Sangamo is a biopharma company focused on the research, development and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies for unmet medical needs.
Sangamo is a biopharma company focused on the research, development and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies for unmet medical needs.
HIV-Therapeutics is developing a therapeutic vaccine against HIV infections and AIDS.
Lumora is a biotech company applying its proprietary technology to propose innovative molecular diagnostics in sample preparation, amplification and detection. Lumora aims to reduce the complexity of molecular testing.
DNA-directed RNA Interference (ddRNAi) is Benitec’s RNAi platform for gene silencing, with several advantages over other methods of gene silencing such as siRNA, anti-sense and zinc finger nucleases.
Synexa Life Sciences is a diversified biotechnology company manufacturing high value, difficult-to-produce microbial secondary metabolites for pharmaceutical industries. Synexa uses a combination of traditional and proprietary cell culture technologies coupled with advanced automated purification systems in their production process.